Respiratory Syncytial Virus, or RSV, is a viral pathogen that causes severe lung infections, including bronchiolitis (infection of small airways in the lungs) and pneumonia (infection of the lungs). It accounts for about 33 million cases of acute lower respiratory tract infection (LRTI) worldwide in children under the age of 5 years each year and is a leading cause of hospitalization in infants.
There are a few RSV vaccines available, including AstraZeneca/Sanofi's Beyfortus, Pfizer's Abrysvo, and GSK's Arexvy, designed to prevent RSV disease in infants and older adults at higher risk of hospitalization or death. Additionally, antivirals like Virazole are used to treat severe lower respiratory tract infections in hospitalized infants and young children.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.